PRECISION MOLECULAR
Live / Registered — Registered (as of 27 Feb 2024)
What this means for you
Registered since 27 Feb 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97141177
- Registration number
- 7316899
- Mark type
- Design + words
- Filed
- 24 Nov 2021
- Published for opposition
- 14 Feb 2023
- Registered
- 27 Feb 2024
- Attorney of record
- Todd S. Bontemps
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic biomarker reagents for medical purposes; molecular imaging and detection agents in the nature of optical and radiopharmaceutical agents for diagnosing and monitoring cancer, neurological diseases, and neurodegenerative diseases; molecular imaging and detection agents in the nature of optical and radiopharmaceutical agents for providing therapy and radiotherapy to patients with cancer, neurological diseases, or neurodegenerative diseases
Owner
- Precision Molecular Inc., Gaithersburg, MD, US
- Precision Molecular Inc., Gaithersburg, MD, US
- Precision Molecular Inc., Gaithersburg, MD, US
Prosecution history
- 27 Feb 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Feb 2024 — REGISTERED-PRINCIPAL REGISTER
- 20 Jan 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Jan 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Jan 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Dec 2023 — USE AMENDMENT FILED
- 06 Jan 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Dec 2023 — TEAS STATEMENT OF USE RECEIVED
- 10 Oct 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Oct 2023 — SOU EXTENSION 1 GRANTED
- 06 Oct 2023 — SOU EXTENSION 1 FILED
- 06 Oct 2023 — SOU TEAS EXTENSION RECEIVED
- 11 Apr 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Feb 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Feb 2023 — PUBLISHED FOR OPPOSITION